New wearable capnograph could revolutionize ambulance monitoring
NCT ID NCT06905613
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new wearable capnograph called MARIE in an ambulance setting. The device measures exhaled carbon dioxide and breathing rate. 20 healthy volunteers and 30 patients being transported by ambulance participated. The goal was to see if the device gives reliable readings during transport.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Wearable capnograph (MARIE) device
- What this could lead to
- If successful, this could lead to better monitoring of patients during ambulance transport, potentially enabling earlier treatment.
- What could go wrong
- This is a small, early feasibility study with only 49 participants. The device may not work reliably in real-world conditions, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMBULANCES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ambulansstationen Uppsala Region
Uppsala, Uppsala County, 75185, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.